Press Release: Government decision on cannabis-related medicinal products draws criticism from independent scientific body, Drug Science.

Today (13th August 2019), the independent scientific body Drug Science has responded with disappointment to a decision by the National Institute for Health and Care Excellence (NICE), relating to cannabis-related medical products. In November 2018, the then Home Secretary Sajid Javid introduced regulations so that cannabis-derived medicinal products would be available on prescription. This change  …


Drug Science Announce a 20,000 Patient UK National Medical Cannabis Pilot: Project TWENTY21

Drug Science’s newly formed medical cannabis working group, which includes the United Patients Alliance, several academic researchers and several medical cannabis companies, is launching the UK’s first national pilot for medical cannabis: Project TWENTY21 Project TWENTY21 aims to enrol 20,000 patients into the pilot before the end of 2021, using a real word data patient  …


Drug Science's 10th birthday at the House of Lords: past achievements and a bright future

Drug Science Patron Lord Nic Rea, hosted Drug Science committee members, trustees, and community supporters at House of Lords on Wednesday, celebrating ten years of achievements, and new initiatives in medical cannabis and psychedelic research. In the beautiful Cholmondeley Room of Westminster Palace, 150 of Drug Science’s supporters heard CEO David Badcock welcome guests and  …


Cannabis health information labels: why it’s time to have mandatory warnings as part of any legal cannabis market

Prof. Adam Winstock – Global Drug Survey 2019 As the tide of cannabis regulatory reform wafts through North America and beyond, it strikes me that the cannabis legalisation lobby started from a strong position. The weight of evidence and cogent arguments at their disposal to counter the totally unhelpful criminalisation of cannabis users was enormous.  …